{"id":"https://openalex.org/W2010745992","doi":"https://doi.org/10.1016/s2214-109x(15)70093-8","title":"Scaling up multidrug-resistant tuberculosis care in China","display_name":"Scaling up multidrug-resistant tuberculosis care in China","publication_year":2015,"publication_date":"2015-03-18","ids":{"openalex":"https://openalex.org/W2010745992","doi":"https://doi.org/10.1016/s2214-109x(15)70093-8","mag":"2010745992","pmid":"https://pubmed.ncbi.nlm.nih.gov/25794667","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4492310"},"language":"en","primary_location":{"id":"doi:10.1016/s2214-109x(15)70093-8","doi":"https://doi.org/10.1016/s2214-109x(15)70093-8","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2214-109x(15)70093-8","pdf_url":null,"source":{"id":"https://openalex.org/S4210176958","display_name":"The Lancet Global Health","issn_l":"2214-109X","issn":["2214-109X","2572-116X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Global Health","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/s2214-109x(15)70093-8","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004903121","display_name":"Karen Rita Jacobson","orcid":"https://orcid.org/0000-0003-4239-3685","observed_orcids":["https://orcid.org/0000-0003-4239-3685"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen R Jacobson","raw_affiliation_strings":["Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: karen.jacobson@bmc.org","Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: karen.jacobson@bmc.org","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021895027","display_name":"Lora Sabin","orcid":"https://orcid.org/0000-0002-2782-542X","observed_orcids":["https://orcid.org/0000-0002-2782-542X"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lora L Sabin","raw_affiliation_strings":["Department of Global Health, Boston University School of Public Health, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Health, Boston University School of Public Health, Boston, MA, USA","institution_ids":["https://openalex.org/I111088046"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I111088046"],"apc_list":{"value":6680,"currency":"USD","value_usd":6680},"apc_paid":{"value":6680,"currency":"USD","value_usd":6680},"fwci":0.2599,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.62075999,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"3","issue":"4","first_page":"e183","last_page":"e184"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistant-tuberculosis","display_name":"multidrug-resistant tuberculosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-susceptibility-testing","display_name":"drug susceptibility testing","score":0.7179999947547913},{"id":"https://openalex.org/keywords/rapid-molecular-diagnostics","display_name":"rapid molecular diagnostics","score":0.7820000052452087},{"id":"https://openalex.org/keywords/directly-observed-therapy","display_name":"directly observed therapy","score":0.7910000085830688},{"id":"https://openalex.org/keywords/treatment-funding","display_name":"treatment funding","score":0.43799999356269836},{"id":"https://openalex.org/keywords/patient-retention","display_name":"patient retention","score":0.6299999952316284},{"id":"https://openalex.org/keywords/linkage-to-care","display_name":"linkage to care","score":0.38600000739097595},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.5590000152587891},{"id":"https://openalex.org/keywords/health-care-financing","display_name":"health care financing","score":0.3240000009536743},{"id":"https://openalex.org/keywords/dietary-supplements","display_name":"dietary supplements","score":0.4569999873638153},{"id":"https://openalex.org/keywords/treatment-default","display_name":"treatment default","score":0.3019999861717224},{"id":"https://openalex.org/keywords/middle-income-countries","display_name":"middle-income countries","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.7534111738204956},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.5843385457992554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5155556201934814},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.4786283075809479},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.4370572566986084},{"id":"https://openalex.org/C205649164","wikidata":"https://www.wikidata.org/wiki/Q1071","display_name":"Geography","level":0,"score":0.2885138988494873},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.25919395685195923},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.21532881259918213},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.20255222916603088},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16764512658119202},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0820397436618805},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018088","descriptor_name":"Tuberculosis, Multidrug-Resistant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1016/s2214-109x(15)70093-8","doi":"https://doi.org/10.1016/s2214-109x(15)70093-8","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2214-109x(15)70093-8","pdf_url":null,"source":{"id":"https://openalex.org/S4210176958","display_name":"The Lancet Global Health","issn_l":"2214-109X","issn":["2214-109X","2572-116X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Global Health","raw_type":"journal-article"},{"id":"pmid:25794667","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25794667","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Global health","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:3457274","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4492310","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4492310","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4492310","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Lancet Glob Health","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:346f99c7ee3d493a8b6c06d7d53480bc","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/346f99c7ee3d493a8b6c06d7d53480bc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Lancet Global Health, Vol 3, Iss 4, Pp e183-e184 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/s2214-109x(15)70093-8","doi":"https://doi.org/10.1016/s2214-109x(15)70093-8","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2214-109x(15)70093-8","pdf_url":null,"source":{"id":"https://openalex.org/S4210176958","display_name":"The Lancet Global Health","issn_l":"2214-109X","issn":["2214-109X","2572-116X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Global Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G6801515933","display_name":"Geospatial clustering and molecular and social epidemiology of drug resistant TB","funder_award_id":"K01TW009213","funder_id":"https://openalex.org/F4320337356","funder_display_name":"Fogarty International Center"}],"funders":[{"id":"https://openalex.org/F4320337356","display_name":"Fogarty International Center","ror":"https://ror.org/02xey9a22"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1977881210","https://openalex.org/W2062911011","https://openalex.org/W2127875000","https://openalex.org/W2138464852","https://openalex.org/W2138699271","https://openalex.org/W2158794355","https://openalex.org/W2169609545"],"related_works":["https://openalex.org/W2138699271","https://openalex.org/W2044266925","https://openalex.org/W2165898417","https://openalex.org/W2784072145","https://openalex.org/W2063296793","https://openalex.org/W1989125447","https://openalex.org/W4308589997","https://openalex.org/W2102615493","https://openalex.org/W2135070766","https://openalex.org/W2416171806"],"abstract_inverted_index":{"Drug-resistant":[0],"tuberculosis":[1,7,11,40,78,148,299,506,599,668,753],"threatens":[2],"to":[3,16,24,79,93,104,108,192,200,295,346,369,383,412,481,565,635,699,782,787,794],"undermine":[4],"advances":[5,751],"in":[6,155,219,287,342,352,372,392,507,524,550,569,591,752],"control":[8],"worldwide.":[9],"Multidrug-resistant":[10],"(MDRTB),":[12],"defined":[13],"as":[14,614,719],"resistance":[15,74,238,662],"isoniazid":[17,278],"and":[18,30,75,87,111,122,135,150,186,222,230,244,247,261,279,282,289,331,349,362,374,380,417,437,453,470,533,552,640,717,729,736,768,785],"rifampicin,":[19],"requires":[20],"treatment":[21,112,259,347,704,724,754],"for":[22,96,120,132,163,211,235,250,277,398,450,465,475,659,705,749,770],"up":[23,564],"24":[25],"months":[26],"with":[27,39,98,165,315,338,434,467,563,608,644,656,738,747],"expensive":[28],"diagnostics":[29,86,469,767],"second-line":[31,688],"drugs.":[32],"Fewer":[33],"than":[34],"15%":[35],"of":[36,49,55,113,117,125,141,175,197,208,225,241,267,270,284,298,310,321,327,355,359,390,401,421,431,440,458,486,496,519,535,577,581,605,652,672,677,682,776],"patients":[37,97,643,655],"diagnosed":[38,356,607],"worldwide":[41],"receive":[42],"drug":[43,661],"susceptibility":[44],"testing":[45,345,464,716],"(DST);":[46],"only":[47,516,595,792],"20%":[48],"the":[50,102,138,176,268,322,353,384,388,447,459,471,487,536,546,570,575,582,592,653,701,720,774],"estimated":[51,167],"480?000":[52],"new":[53,84],"cases":[54,171,639],"MDRTB":[56,158,201,432,441,466,638,657,678,771,789],"annually":[57],"are":[58,726],"treated":[59,313],"appropriately.1":[60],"Of":[61],"these,":[62],"cure":[63],"rarely":[64],"exceeds":[65],"65%.":[66],"Those":[67],"on":[68,189,505,540,597,627,647],"ineffective":[69,648],"therapy":[70],"risk":[71],"acquiring":[72],"additional":[73,579,660],"spreading":[76],"drug-resistant":[77,99],"others.":[80],"In":[81,179],"recent":[82],"years,":[83],"molecular":[85,273,288,468,588,611],"antituberculosis":[88],"drugs":[89,769],"promise":[90],"an":[91,166,190,492,683],"opportunity":[92],"improve":[94],"outcomes":[95,400],"tuberculosis,":[100],"leading":[101],"WHO":[103,302],"prioritise":[105],"universal":[106,198],"access":[107,199],"prevention,":[109],"diagnosis,":[110,425,783],"MDRTB.1":[114],"However,":[115,157],"identification":[116],"viable":[118],"models":[119,725],"coordinating":[121],"financing":[123,234],"scale-up":[124,456,489,788],"such":[126,613,777],"services":[127],"remains":[128,159],"a":[129,160,173,194,206,226,248,271,308,339,409,512,670,745,778],"major":[130,370],"challenge":[131],"most":[133,702],"middle-income":[134],"low-income":[136],"countries.\r\n\r\nAfter":[137],"widespread":[139],"implementation":[140],"directly":[142,251],"observed":[143,252],"therapy,":[144],"short":[145],"course":[146],"(DOTS),":[147],"prevalence":[149],"mortality":[151,547],"have":[152],"decreased":[153],"greatly":[154],"China.2":[156],"formidable":[161],"problem":[162],"China":[164,525],"100":[168],"000":[169],"incident":[170],"annually,":[172,499],"fifth":[174],"global":[177],"burden.3":[178],"The":[180,215,304,334,376,443,587],"Lancet":[181],"Global":[182],"Health,":[183],"Renzhong":[184],"Li":[185,379,551],"colleagues":[187],"report4":[188],"intervention":[191],"provide":[193],"comprehensive":[195,227],"programme":[196,216,460,583],"care,":[202,229],"which":[203,426,601,623],"might":[204],"offer":[205],"model":[207,746],"improved":[209,262,766],"care":[210,263,473,790],"other":[212],"high-burden":[213],"countries.":[214],"was":[217,293],"implemented":[218],"four":[220],"cities":[221],"involved":[223],"provision":[224],"diagnostic,":[228],"financial":[231,305],"package,":[232],"including":[233,462],"specimen":[236],"shipment,":[237],"testing,":[239],"costs":[240],"patient":[242],"transportation":[243],"nutritional":[245],"supplements,":[246],"subsidy":[249],"therapy.":[253],"It":[254],"emphasised":[255],"close":[256],"communication":[257],"between":[258],"facilities":[260],"linkages.":[264],"Diagnosis":[265],"consisted":[266],"use":[269,326,358],"rapid":[272,687],"diagnostic":[274,589,612,697],"(Genechip":[275],"Capitabio)":[276],"rifampicin":[280],"DST":[281],"training":[283],"centralised":[285],"staff":[286],"conventional":[290],"DST.":[291],"Treatment":[292],"tailored":[294],"confirmed":[296],"degree":[297],"resistance,":[300],"per":[301,312],"guidelines.":[303],"scheme":[306],"imposed":[307],"cap":[309],"US$4644":[311],"case,":[314],"patients'":[316],"expenses":[317],"capped":[318],"at":[319,364,733],"10%":[320],"total,":[323],"through":[324],"creative":[325],"government":[328],"insurance":[329],"funds":[330],"project":[332],"resources.":[333],"results":[335],"were":[336,602],"impressive,4":[337],"90%":[340],"decrease":[341],"time":[343,411],"from":[344,378,713],"initiation":[348,439,681],"substantial":[350,513],"increases":[351],"number":[354,510],"patients,":[357],"appropriate":[360],"regimen,":[361],"retention":[363],"6":[365,404],"months,":[366],"largely":[367],"due":[368],"decreases":[371],"deaths":[373,556,567],"defaults.":[375],"findings":[377],"colleagues4":[381],"add":[382],"mounting":[385],"evidence":[386],"that":[387,408,446,762],"prioritisation":[389],"investments":[391],"operational":[393],"coordination":[394],"improvements":[395],"is":[396,511],"crucial":[397],"better":[399],"MDRTB.4,":[402],"5,":[403],"Specifically,":[405],"they":[406,692],"show":[407],"faster":[410,438],"diagnosis":[413],"has":[414],"both":[415],"clinical":[416],"cost":[418,490,786],"benefits:":[419],"elimination":[420],"hospital":[422,435],"stay":[423],"preceding":[424],"reduces":[427],"potential":[428,748],"nosocomial":[429],"transmission":[430],"along":[433],"expenses,":[436],"treatment.":[442],"investigators":[444],"note":[445],"National":[448],"Center":[449],"Tuberculosis":[451],"Control":[452],"Prevention":[454],"will":[455,791],"features":[457],"nationwide,":[461],"free":[463],"standard":[472],"package":[474],"MDRTB.":[476],"This":[477,509,742],"investment":[478],"would":[479],"seem":[480],"be":[482,558,585,625,633,694,711],"wise.":[483],"An":[484],"estimate":[485],"national":[488],"suggests":[491],"initial":[493],"price":[494],"tag":[495],"$500":[497],"million":[498],"or":[500,618,629,666],"roughly":[501,561],"double":[502],"domestic":[503],"spending":[504,523],"2011.7":[508],"figure,":[514],"but":[515],"about":[517],"0\u00b72%":[518],"annual":[520],"public":[521],"health":[522],"(an":[526],"amount":[527],"considered":[528],"low":[529],"by":[530,560],"international":[531],"standards)":[532],"80%":[534],"government's":[537],"yearly":[538],"outlay":[539],"HIV.8,":[541],"9,":[542],"10":[543],"Moreover,":[544],"extrapolating":[545],"effect":[548],"shown":[549],"colleagues'":[553],"study,4":[554],"MDRTB-related":[555],"could":[557,632,710],"reduced":[559],"80%,":[562],"20?000":[566],"averted":[568],"first":[571],"year":[572],"alone.\r\n\r\nTo":[573],"maximise":[574],"chances":[576],"success,":[578],"elements":[580],"should":[584,693],"considered.":[586],"used":[590],"study's":[593],"package4":[594],"performs":[596],"smear-positive":[598],"cases,":[600],"just":[603],"28%":[604],"those":[606],"tuberculosis.":[609],"A":[610],"Xpert":[615],"MTB/RIF":[616],"(Cepheid)":[617],"MTBDRplus":[619],"(Hain":[620],"Lifescience":[621],"GmbH),":[622],"can":[624],"done":[626],"smear-negative":[628,645],"culture-positive":[630],"specimens,":[631],"incorporated":[634,695],"capture":[636],"all":[637,706,734],"avoid":[641],"initiating":[642],"samples":[646],"therapy.11":[649],"47":[650],"(29%)":[651],"163":[654],"tested":[658],"had":[663],"extensively":[664],"(XDR)":[665],"pre-XDR":[667],"discovered":[669],"median":[671],"45\u201355":[673],"days":[674],"after":[675],"start":[676],"treatment,":[679,718,784],"delaying":[680],"effective":[684,703],"regimen.":[685],"As":[686,765],"DSTs":[689],"become":[690,772],"available,":[691,773],"into":[696],"schemes":[698],"ensure":[700],"patients.":[707],"Further":[708],"benefits":[709],"gained":[712],"integrating":[714],"HIV":[715],"authors":[721],"acknowledge.4\r\n\r\nComprehensive,":[722],"high-quality":[723],"challenging":[727],"logistically":[728],"financially,":[730],"demanding":[731],"commitment":[732],"levels":[735],"implementers":[737],"considerable":[739],"technical":[740],"expertise.":[741],"study":[743],"offers":[744],"achieving":[750],"relatively":[755],"swiftly,":[756],"while":[757],"highlighting":[758],"important":[759],"policy":[760],"issues":[761],"merit":[763],"attention.":[764],"relevance":[775],"complete,":[779],"integrated":[780],"approach":[781],"continue":[793],"grow.":[795]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}